Revvity
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.
Latest Revvity Content
Infographic
Gain Deeper Insights From Your 3D Cell Model Imaging
This infographic explores innovative tools and strategies for enhancing 3D cell model imaging that can help you achieve high-quality images and efficiently manage data.
How To Guide
Top Tips for Enhancing Single-Cell Sequencing
This guide explores the nuances of these challenges and presents promising strategies designed to overcome them, enabling researchers to access the full spectrum of cellular diversity and function in health and disease.
Video
Drug Discovery and CROs: A Journey Beyond Spreadsheets and Email
In this episode, we speak with Chris Stumpf, Director, Drug Discovery Informatics Solutions at Revvity Signals.
App Note / Case Study
A Novel Approach for Non-Invasive Liver Research
This case study utilizes non-invasive ultrasound imaging to visualize and quantify liver echogenicity and stiffness, providing critical insights into both disease progression and the efficacy of therapeutic interventions in mouse models.
Product News
Early Check Newborn Screening Study Taps Revvity To Provide Genome Sequencing
The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions.
Product News
Revvity Unveils a New Era of Automated Tuberculosis Testing
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.
Product News
Revvity Unveils a New Era of Automated Tuberculosis Testing
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.
Product News
Early Check Newborn Screening Study Taps Revvity To Provide Genome Sequencing
RTI International has announced that Early Check, a groundbreaking research study that provides free voluntary health tests for newborns up to four weeks old in North Carolina, has chosen Revvity, Inc. to conduct genome sequencing for the study starting in May.
Product News
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight.
Product News
Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research
Designed to build the foundation for diagnosing rare diseases in the future. Ability to perform workflow analysis through in-house global laboratory network.
Advertisement
